AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Pacira BioSciences, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S77N12
36.42▲ 0.08 (0.22%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
36.34
Day's Range
36.33 – 36.42
52-Week Range
18.80 – 36.67
Volume
574.3K
Avg Volume
1.9M
Share Statistics
Shares Outstanding
Employees
829
Exchange
XNAS
Listed
2011-02-03
Share count as of August 3, 2026

Pacira BioSciences, Inc. Common Stock (PCRX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Pacira BioSciences, Inc. Common Stock (PCRX)
What is Pacira BioSciences, Inc. Common Stock's Market Cap?
Pacira BioSciences, Inc. Common Stock's Market Cap is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Pacira BioSciences, Inc. Common Stock's Enterprise Value?
Pacira BioSciences, Inc. Common Stock's Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Pacira BioSciences, Inc. Common Stock's Trailing P/E?
Pacira BioSciences, Inc. Common Stock's Trailing P/E is 99.2×, based on as-reported figures from SEC (XBRL) filings.
What is Pacira BioSciences, Inc. Common Stock's Price / Sales?
Pacira BioSciences, Inc. Common Stock's Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is Pacira BioSciences, Inc. Common Stock's EV / Revenue?
Pacira BioSciences, Inc. Common Stock's EV / Revenue is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is Pacira BioSciences, Inc. Common Stock's EV / EBITDA?
Pacira BioSciences, Inc. Common Stock's EV / EBITDA is 14.9×, based on as-reported figures from SEC (XBRL) filings.
What is Pacira BioSciences, Inc. Common Stock's Revenue (TTM)?
Pacira BioSciences, Inc. Common Stock's Revenue (TTM) is $746.2M, based on as-reported figures from SEC (XBRL) filings.
What is Pacira BioSciences, Inc. Common Stock's Net Income (TTM)?
Pacira BioSciences, Inc. Common Stock's Net Income (TTM) is $14.6M, based on as-reported figures from SEC (XBRL) filings.
What is Pacira BioSciences, Inc. Common Stock's EBITDA?
Pacira BioSciences, Inc. Common Stock's EBITDA is $105.0M, based on as-reported figures from SEC (XBRL) filings.
What is Pacira BioSciences, Inc. Common Stock's Diluted EPS (TTM)?
Pacira BioSciences, Inc. Common Stock's Diluted EPS (TTM) is 0.37, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PCRXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Total revenues
YoY growth+6.2%+5.0%+5.1%+6.5%
Operating expenses:
Cost of goods sold (exclusive of amortization of acquired intangible assets)
Research and development
Selling, general and administrative
Amortization of acquired intangible assets
Other operating expenses, net——
Total operating expenses
% of revenue97.8%96.1%98.8%96.5%
Income from operations
% of revenue2.2%3.9%1.2%3.5%
Other income (expense):
Interest income
Interest expense
Other, net
Total other expense, net
Income (loss) before income taxes
Income tax benefit (expense)
Net income (loss)
% of revenue2.4%1.6%0.8%3.0%
Basic net income (loss) per common share (in dollars per share)
Diluted net income (loss) per common share (in dollars per share)